Ying Chen

8.8k citations

239 papers · 6.2k indexed · 2 hit papers · h-index 38

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Hematology 37
- Acute Myeloid Leukemia Research 19
- Hematopoietic Stem Cell Transplantation 11
Nephrology 18
- Chronic Kidney Disease and Diabetes 12

Co-authors: John W. Lyga (1 shared paper)Yang Yang (13 shared papers)Kathleen M. Giacomini (3 shared papers)Zuwei Li (1 shared paper)Jian‐xing Ma (3 shared papers)Naveed Shaik (2 shared papers)Sagar Agarwal (2 shared papers)William F. Elmquist (2 shared papers)
Journals: Blood (6 papers)Frontiers in Immunology (5 papers)Frontiers in Medicine (4 papers)Annals of Hematology (4 papers)Journal of Advanced Research (4 papers)
Partner nations: China United States Japan

In The Last Decade

Ying Chen

216 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases 2024 · 141 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Signal Transduction and Targeted Therapy
2023 Cellular & Molecular Biology Letters

Peers

Countries citing papers authored by Ying Chen

Since Specialization

Citations

This map shows the geographic impact of Ying Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chen more than expected).

Fields of papers citing papers by Ying Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chen. The network helps show where Ying Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Ying Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ying Chen Line = papers co-authored together Ying Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity Cancer Research ·Shuzhong Zhang, Katherine S. Lovejoy, James E. Shima, Leah L. Lagpacan, Yan Shu, Anna Lapuk, Ying Chen, Takafumi Komori, Joe W. Gray, Xin Chen, Stephen J. Lippard, Kathleen M. Giacomini	2006	340
2	Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor-E2–related factor-2 transcriptional pathway Hepatology ·Jonathan Maher, Matthew Z. Dieter, Lauren M. Aleksunes, Angela L. Slitt, Grace L. Guo, Yuji Tanaka, George L. Scheffer, Jefferson Y. Chan, José E. Manautou, Ying Chen, Timothy P. Dalton, Masayuki Yamamoto, Curtis D. Klaassen	2007	263
3	KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma Cancer Immunology Immunotherapy ·Nan Chen, Wenfeng Fang, Lin Zhong, Peijian Peng, Juan Wang, Jianhua Zhan, Shaodong Hong, Jiaxing Huang, Lin Liu, Sheng Jin, Ting Zhou, Ying Chen, Hongyu Zhang, Li Zhang	2017	236
4	Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease Blood ·Tangsheng Yi, Ying Chen, Lin Wang, Gong Du, Daniel Q. Huang, Dongchang Zhao, Heather F Johnston, James S. Young, Иван Тодоров, Dale T. Umetsu, Lieping Chen, Yoichiro Iwakura, Fouad Kandeel, Stephen J. Forman, Defu Zeng	2009	222
5	The NLRP3 inflammasome: contributions to inflammation-related diseases Cellular & Molecular Biology Letters ·Ying Chen, Xingyan Ye, Germaine Escames, Wangrui Lei, Xin Zhang, Meng Li, Tong Jing, Yu Yao, Zhenye Qiu, Zheng Wang, Darío Acuña‐Castroviejo, Yang Yang Hit paper breakdown →	2023	200
6	Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors Clinical Cancer Research ·Anthony W. Tolcher, Mario Sznol, Siwen Hu‐Lieskovan, Kyriakos P. Papadopoulos, Amita Patnaik, Drew Rasco, Donna Di Gravio, Bo Huang, Dhiraj Gambhire, Ying Chen, Aron D. Thall, Nazima Pathan, Emmett V. Schmidt, Laura Q.M. Chow	2017	183
7	NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model Behavioural Brain Research ·Wenjun Su, Yi Zhang, Ying Chen, Hong Gong, Yong‐Jie Lian, Peng Wei, Yun‐Zi Liu, Yunxia Wang, Zili You, Shi-Jie Feng, Ying Zong, Guocai Lu, Chun‐Lei Jiang	2017	183
8	Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer Clinical Cancer Research ·Neil H. Segal, Aiwu Ruth He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari, Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, Ajay K. Gopal	2018	181
9	Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin Pharmacogenetics and Genomics ·Ying Chen, Shuanglian Li, Chaline Brown, S. Christian Cheatham, Richard A. Castro, Maya K. Leabman, Thomas Urban, Ligong Chen, Sook Wah Yee, Ji Ha Choi, Yong Huang, Claire M. Brett, Esteban G. Burchard, Kathleen M. Giacomini	2009	174
10	Brain-Skin Connection: Stress, Inflammation and Skin Aging Inflammation & Allergy - Drug Targets ·Ying Chen, John W. Lyga	2014	171
11	Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment Journal of Neuroinflammation ·Zhi Wang, Shiyu Meng, Lin Cao, Ying Chen, Zhiyi Zuo, Shuling Peng	2018	163
12	Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma Cell Death Discovery ·Wanli Lin, Ying Chen, Bomeng Wu, Zuwei Li	2021	156
13	P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib Journal of Pharmacology and Experimental Therapeutics ·Ying Chen, Sagar Agarwal, Naveed Shaik, Cliff Chen, Zheng Yang, William F. Elmquist	2009	155
14	Rapamycin Prevents Early Steps of the Development of Diabetic Nephropathy in Rats American Journal of Nephrology ·Yi Yang, Jingjing Wang, Qin Ling, Zhangfei Shou, Jie Zhao, Huiping Wang, Ying Chen, Jianghua Chen	2007	149
15	Cell-specific translational profiling in acute kidney injury Journal of Clinical Investigation ·Jing Liu, A. Michaela Krautzberger, Shannan Ho Sui, Oliver Hofmann, Ying Chen, Manfred Baetscher, Ivica Grgic, Sanjeev Kumar, Benjamin D. Humphreys, (unknown), Andrew P. McMahon	2014	142
16	Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases Signal Transduction and Targeted Therapy ·Qian Lu, Yanli Zhu, Chao Deng, Zhenxing Liang, Junmin Chen, Ying Chen, Xue Wang, Yanqing Liu, Ye Tian, Yang Yang Hit paper breakdown →	2024	141
17	The Role and Mechanism of Pyroptosis and Potential Therapeutic Targets in Sepsis: A Review Frontiers in Immunology ·Xiangtao Zheng, Weiwei Chen, Fangchen Gong, Ying Chen, Erzhen Chen	2021	138
18	Intercomparison of methods for image quality characterization. I. Modulation transfer functiona) Medical Physics ·Ehsan Samei, Nicole T. Ranger, James T. Dobbins, Ying Chen	2006	135
19	Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies Blood ·Christian A. Di Buduo, Lindsay S. Wray, Lorenzo Tozzi, Alessandro Malara, Ying Chen, Chiara E. Ghezzi, Daniel Smoot, Carla Sfara, A. Antonelli, Elise Spedden, Giovanna Bruni, Cristian Staii, Luigi De Marco, Mauro Magnani, David L. Kaplan, Alessandra Balduini	2015	113
20	RPE65 Is an Iron(II)-dependent Isomerohydrolase in the Retinoid Visual Cycle Journal of Biological Chemistry ·Gennadiy Moiseyev, Yusuke Takahashi, Ying Chen, Susan Gentleman, T. Michael Redmond, Rosalie K. Crouch, Jian‐xing Ma	2005	99

About Ying Chen

Ying Chen is a scholar working on Hematology, Nephrology, Oncology, Critical Care and Intensive Care Medicine and Biological Psychiatry, having authored 239 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Inflammasome and immune disorders (14 papers), Immune Cell Function and Interaction (14 papers), Drug Transport and Resistance Mechanisms (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Chronic Kidney Disease and Diabetes (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Biological Psychiatry (224 citations), Oncology (1.7k citations), Immunology (1.1k citations), Nephrology (314 citations) and Hematology (438 citations). Ying Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include John W. Lyga, Yang Yang, Kathleen M. Giacomini, Zuwei Li, Jian‐xing Ma, Naveed Shaik, Sagar Agarwal, William F. Elmquist, Shuzhong Zhang and Ehsan Samei. Their work appears in journals such as Blood, Frontiers in Immunology, Frontiers in Medicine, Annals of Hematology and Journal of Advanced Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact